Clinical Trial Detail

NCT ID NCT02786485
Title Study of Matched Unrelated Donor T Cell Infusion for Hematologic Malignancies After Allo-HSCT
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bellicum Pharmaceuticals
Indications

myelodysplastic syndrome

lymphoma

leukemia

multiple myeloma

Therapies

Rimiducid

BPX-501

Age Groups: adult

No variant requirements are available.